# Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow

> **NCT04594239** · NA · COMPLETED · sponsor: **Merz North America, Inc.** · enrollment: 150 (actual)

## Conditions studied

- Volume Loss in the Infraorbital Hollow Area

## Interventions

- **DEVICE:** Belotero Balance (+) Lidocaine, needle
- **DEVICE:** Belotero Balance (+) Lidocaine, cannula
- **DEVICE:** Untreated-control / delayed-treatment, needle
- **DEVICE:** Untreated-control / delayed-treatment, cannulas

## Key facts

- **NCT ID:** NCT04594239
- **Lead sponsor:** Merz North America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-31
- **Primary completion:** 2021-04-08
- **Final completion:** 2022-06-21
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04594239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04594239, "Evaluation of Effectiveness and Safety of Belotero Balance® (+) Lidocaine for Volume Augmentation of the Infraorbital Hollow". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04594239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*